Bristol-Myers Squibb experiences a series of upturns and downturns. It outperformed revenue expectations and announced a $1.5 billion cost cut, despite making a quarterly loss. There's speculation around the company's stock being a potential 'millionaire maker', underpinned by its strong dividend play. However, concerns lay with its level of debt and recent layoffs as part of cost-cutting measures. The company is passionate about innovation; a notion reflected in its pharmaceutical successes and forthcoming product launches. Bristol-Myers Squibb expects to launch 16 new products through 2030, according to the CEO.
Bristol-Myers Squibb BMY News Analytics from Thu, 26 Oct 2023 07:00:00 GMT to Tue, 07 May 2024 14:34:58 GMT -
Rating -3
- Innovation 6
- Information 7
- Rumor 4
